Effective adaptive immune responses require a large naïve T cell repertoire that migrates throughout the body, rapidly identifying virtually any foreign peptide 1 . Because T cell production declines with age, naïve T cells must be long-lived 2 . Yet how naïve T cells survive for years while travelling constantly remains unclear. The chemoattractant sphingosine 1-phosphate (S1P) guides T cell circulation among secondary lymphoid organs -spleen, lymph nodes (LN), and Peyer's patches -where they search for antigen. The concentration of S1P is high in circulatory fluids compared to lymphoid organs, and S1P receptor 1 (S1PR1) directs T cell exit from spleen into blood, and from LN and Peyer's patches into lymph 3 . Here we find that S1P is essential not only for naïve T cell circulation, but also survival. We provide evidence that lymphatic endothelial cells support T cell survival by secreting S1P via the transporter SPNS2, that this S1P signals through S1PR1 on T cells, and that the requirement for S1PR1 is independent of S1PR1's established role in guiding exit from LN. S1P signaling maintains naïve T cell mitochondrial content, providing Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:
There are many possible explanations for the increased T cell death; indeed, SPNS2 may transport more substrates than S1P. But two changes that T cells in Spns2Δ mice experience are: (1) they no longer circulate, and (2) they are exposed to less S1P (they no longer sense S1P periodically in blood and lymph, or low levels of S1P within the LN parenchyma) 12 . We asked whether restoring S1P exposure without restoring circulation could rescue T cell survival. We treated Spns2Δ mice and littermate controls with 4-deoxypyridoxine (DOP), which inhibits the S1P-degrading enzyme S1P lyase. DOP increases extracellular S1P in LN of WT mice, and traps T cells in LN by flattening the S1P gradient that drives exit 13 . To confirm that DOP treatment also increased LN S1P in Spns2Δ mice, we took advantage of the fact that S1PR1 is internalized upon binding ligand 13, 14 . Surface S1PR1 was 5-fold higher on T cells in vehicle-treated Spns2Δ mice than littermate controls, reflecting lower exposure to S1P (Fig. ED5a-c) . S1PR1 was internalized on T cells in both DOP-treated control and Spns2Δ mice, indicating that S1P exposure had increased (Fig. ED5a-c) . In Spns2Δ mice, this was due to S1P secretion by cells not targeted by Lyve1-Cre or SPNS2-independent secretion. DOP did not restore the S1P gradient required for exit, as there was no increase in circulating T cells in DOP-treated compared to vehicle-treated Spns2Δ mice signaling, independent of a role in egress, supports T cell survival.
We next considered whether an S1P receptor controls T cell survival. Naïve T cells express S1PR1 and S1PR4, but we saw no loss of S1pr4 −/− T cells in LN (Fig. ED6) . A role of S1PR1 in T cell survival has not been addressed because S1pr1 −/− T cells do not leave the thymus 15, 16 . To test this, we bred mice in which S1pr1 could be inducibly deleted. We thymectomized adult S1pr1 f/f UBC-CreERT2 mice and littermate controls; then treated both groups with tamoxifen to delete S1pr1; and analyzed the mice 12 weeks later. Like Spns2Δ mice, S1pr1-deficient mice (S1pr1Δ; tamoxifen-treated S1pr1 f/f UBC-CreERT2 animals) had a reduction in peripheral naïve T cells and higher frequency of dying naïve T cells (Fig. 3a,b , Fig. ED7a,b) . Mixed BM chimeras revealed that the survival defect was T cell-intrinsic (Fig.  3c,d, Fig. ED7c,d ). Consistent with a cell-intrinsic role for S1PR1, naïve S1pr1Δ T cells isolated from mixed BM chimeras showed down-regulation of transcripts associated with survival and up-regulation of transcripts associated with death ( Fig. ED7e) . DOP treatment of S1pr1Δ mice did not rescue cell death, suggesting that the restored T cell survival in DOP-treated Spns2Δ mice was likely mediated by S1PR1 signaling (Fig. ED8 ).
We next asked how SPNS2/S1P/S1PR1 signaling supports T cell survival. Two extrinsic factors are known to support T cell survival -IL7 and self-peptide/MHC 17-19 -but we found little evidence that S1PR1 signaling regulates access to these (Fig. ED9 ). This seems unlike the role of CCL19/CCR7 signaling, which also supports T cell survival but does not have an additive effect with loss of IL7 signaling in vivo 20 .
Naïve T cells rely on oxidative phosphorylation and decline in numbers with mitochondrial dysfunction 21 . We observed a reduction in levels of the mitochondrial proteins VDAC1 and COXIV in S1pr1Δ T cells compared to littermate controls (Fig. 4a,b) . We further observed a 40% decrease in staining for total mitochondria in S1pr1Δ T cells, and a similar decrease in staining for functional mitochondria using MitoTracker CMX-Ros, whose accumulation depends on mitochondrial membrane potential (Fig. 4c,d, Fig. ED10a ). S1pr1Δ T cells also had lower oxygen consumption rates (OCR) than littermate controls (Fig. 4e,f, Fig. ED10f ). This decrease is unlikely to be secondary to cells undergoing apoptosis, because only a small fraction of cells is detectably apoptotic (Fig. 3b) and because BCL2-Tg S1pr1Δ T cells have a reduced rate of apoptosis (Fig. ED10b,c ) but no increase in respiration (Fig 4f, Fig.  ED10d-f ). T cells utilize both oxidative phosphorylation and aerobic glycolysis upon activation, and activated S1pr1Δ T cells proliferated less than controls when relying primarily on oxidative phosphorylation in medium containing galactose, but similarly to controls when able to perform glycolysis efficiently in the presence of glucose (Fig. ED10g-j) 21, 22 . The loss of mitochondria appears specific, as we saw no reproducible decrease in the endoplasmic reticulum (ER) protein calnexin or substantial evidence of ER stress, and the ratio of β-actin to total cell numbers was unchanged (Fig. 4a,b, Fig. ED10k,l) . We observed increased deposition of ubiquitin on mitochondria in S1pr1Δ T cells, suggesting that mitochondrial loss may be due at least partly to mitophagy (Fig. 4g,h ). Consistent with this, S1pr1Δ T cells had increased levels of PINK1, a kinase that accumulates upon mitochondrial dysfunction and induces ubiquitination of mitochondrial proteins (Fig. 4i,j) 23 . These data suggest that S1PR1 signaling is required in naïve T cells to maintain mitochondrial content and function.
We identify S1P as an extrinsic factor supporting naïve T cell survival, and suggest a new role for lymphatic endothelial cells in regulating naïve T cell numbers. Although S1PR1 signaling is routinely described as pro-survival, there has been scant evidence that S1PR1 is limiting in vivo because mice lacking S1PR1 or both sphingosine kinases die at midgestation of hemorrhage 24, 25 , confounding attempts to study a cell-intrinsic role of S1PR1 in survival. Studies of S1PR1 in cultured cells are difficult to interpret because S1P in serum is an artificially dominant signal; in vivo, cells integrate signaling through multiple receptors sharing common downstream pathways. Consistent with previous reports, S1P induces AKT phosphorylation in LN T cells, and future work will address whether this pathway regulates mitochondrial function (Fig. ED10m) 26 . S1PR1's requirement for naïve T cell survival, in context of the many drugs being developed to target S1PR1 signaling, points to the importance of assessing the requirement for S1PR1 in lymphoma and central memory T cells. Given the energy cost of constant migration to sample antigen, use of the same cue that guides circulation to promote mitochondrial function is an efficient way for naïve T cells to supply their required fuel.
Methods

Mice
Spns2 f 5 , S1pr1 f 27 , S1pr4 -28 , Lck-BCL2 transgenic 11 , Lyve1-Cre 10 , UBC-CreERT2 29 , UBC-GFP 30 and MHCII-deficient 31 mice have been previously described. CD45.1 + congenic mice were obtained from Charles River Laboratories. All mice were on a C57BL6 or C57BL6-129 background. Mice were 5-52 weeks old at the time of analysis. Male and female mice were used depending on availability, as sex did not appear to affect the results. In all cases mice were compared to littermate controls. Mice were housed in specific pathogen-free conditions at the Skirball Institute animal facility. No animals were excluded from analysis unless they were clearly sick (hunched, low body weight). These criteria were pre-established, and are standard in the lab. No specific method of randomization was used to allocate mice into groups. The order of sample collection and data acquisition was designed to avoid experimental bias: collection and processing of samples from control and knock-out, as well as treated and untreated animals, were alternated. No blinding was done, as there was no disease scoring. All animal experiments were performed in accordance with protocols approved by the New York University Institutional Animal Care and Use Committee.
Mouse treatments
For bone marrow chimeras, recipients were irradiated with two 6.5 Gray doses of γ irradiation from a cesium source separated by 3 hours, and received 2-10×10 6 bone marrow cells by intravenous injection. Chimeras were analyzed at least 6 weeks after transplantation. Tamoxifen (approximately 75 mg/kg body weight) was administered i.p. on 5 consecutive days. Unless otherwise indicated, analysis was 3 weeks after the last tamoxifen treatment. For adoptive transfer experiments, mice received spleen and LN lymphocytes including 1-3×10 6 naïve CD4 T cells in 0.1 ml by retro-orbital injection. For transfers into MHCIIdeficient recipients, 1-3×10 6 naïve CD4 T cells were sorted and labeled with CellTrace Violet (Molecular Probes) according to the manufacturer's instructions before transfer. 4-deoxypyridoxine-HCl (DOP) treated mice received drinking water with 10g/L sucrose plus 30mg/L DOP (Sigma); vehicle-treated mice received drinking water with 10g/L sucrose. Surgical removal of thymi was performed on intubated adult mice under 2% isoflurane using a ventilator (MiniVent Type 845, Harvard Apparatus). For antibody blockade experiments mice were injected i.p. with 0.1 mg of antibodies and analyzed 5 days after injection. For BrdU labeling, 1 mg BrdU (BD Biosciences) in sterile PBS was injected intraperitoneally every 24 hours for 3 days, and mice were analyzed 24 hours after the last injection.
Cell preparation
Lymphocytes were isolated from thymus, spleen, LN, Peyer's patches, lungs, and liver by mechanical disruption and filtration through a 70 μm cell strainer. LN were combined brachial, axillary, inguinal, and mesenteric. Lymphocytes from the small intestinal lamina propria were isolated after removing the Peyer's patches. The tissue was minced with scissors and shaken vigorously for 1 min in HBSS. Minced intestines were further shaken at 100 rpm for 30 minutes at 37C in HBSS containing HEPES (10 mM), sodium pyruvate (1 mM), EDTA (1mM), and DTT (1 mM). Minced pieces were transferred to HBSS containing HEPES (10 mM), sodium pyruvate (1 mM), EDTA (1mM) and shaken at 100 rpm for 10 minutes at 37C minutes to remove the intestinal epithelial lymphocyte fraction (supernatant). Samples were further digested in 0.5 mg/ml Collagenase D (Roche) and 0.1 mg/ml DNAse I in HBSS shaking at 100 rpm at 37C for 20 minutes. Digested samples were filtered through a 40 μm strainer.. Further purification of lymphocytes from the lungs, liver, and lamina propia was performed by density gradient centrifugation using 40% and 80% Percoll (GE Healthcare). The cells at the interphase of the gradient were collected and washed twice.
Macrophages from LN were isolated by thorough mechanical disruption with scissors in HBSS. Minced LN were digested with Collagenase IV (1 mg/ml, Sigma) with DNAse I (0.2 mg/ml, Roche) for 20 minutes in HBSS at 37C with gentle rocking. Digested LN suspensions were passed through a 100 μm cell strainer. Collagenase IV was inactivated with 5 mM EDTA and 10% FBS in PBS.
Further purification, as necessary, was either by magnetic bead enrichment (Stem Cell Technologies, biotin selection kit, used according to the manufacturer's instructions) or flow cytometry (Beckman Coulter MoFlo or BD Biosciences FACSAria). Lymphocytes were enumerated with a cell counter (Beckman Coulter Multisizer 3) set to detect nuclei between 3.5 and 7 μm.
Antibodies
Antibodies to B220 (clone RA3-6B2), CD4 (clone RMA4-5 or GK1.5), CD8 (clone 53-6.7), CD62L (clone MEL14), CD69 (clone H1.2F3), IL7Rα (clone A7R34), CD44 (clone IM7), Nur77 (clone 12.14), Lyve1 (clone ALY7), MHCII (clone M5/114.12.2), gp38 (clone 8.1.1), CD25 (clone PC61), PINK1 (clone 5E1.D8), and rat IgG2a-κ isotype control (clone RTK2758) were purchased from Biolegend, eBiosciences, or BD Biosciences. Anti-S1PR1 (clone 713412) was purchased from R&D Systems. Anti-pSTAT5 (clone D47E7), anti-AKT (catalogue # 9272), anti-pAKT (clone D9E), anti-S6 (clone 5G10) and anti-pS6 (clone D57.2.2E) were purchased from Cell Signaling Technologies. Anti-VDAC1 (clone 20B12AF2) and anti-COXIV (clone 20E8C12) were purchased from Abcam. Polyclonal anti-calnexin (catalogue #A303-696A) was purchased from Bethyl Laboratories. Polyclonal anti-STAT5 (catalog number C-17) and anti-β-actin (clone C4) were purchased from Santa Cruz Biotechnology. Anti-ubiquitin antibody (clone FK2) was purchased from Enzo Life Sciences. Blocking IL7Rα (clone A7R34) 32 and isotype control (clone 2A3) antibodies were purchased from Bioxcell. AnnexinV and propidium iodide were purchased from Biolegend. CaspACE FITC-VAD-FMK probe for active caspases was purchased from Promega. For flow cytometry, cells were analyzed using an LSRII (BD Biosciences); data were analyzed using FlowJo v. 8.8.1 (Tree Star).
Mitochondrial labeling
Mitochondria were stained using MitoTracker Red CMXRos and MitoTracker Deep Red FM (Life Technologies) according to the manufacturer's instructions. In brief, cells (10E6 cells in 50 μl) were incubated in 2% FBS, 1mM EDTA in PBS containing 0.5 μM MitoTracker dyes along with antibodies for staining cell surface makers for 20 minutes at 37°C. After washing, cells were analyzed using an LSRII (BD Biosciences) or further stained before analysis by confocal microscopy (LSM710; Carl Zeiss).
Microscopy
Confocal imaging was done using standard conditions. In brief, LN were excised, fixed for 1 hour at room temperature in 4% paraformaldehyde, and progressively dehydrated at 4°C in sucrose (10%, 20%, and 30% in PBS). Tissues were snap frozen in OCT compound (Sakura Tissue-Tek). 8 μm tissue sections were cut, rehydrated (rehydration and staining buffer was PBS with 4% mouse serum, 4% rat serum, 10 μg/ml anti-CD16/32, 0.1% Triton X-100), stained, and imaged. Sorted naïve CD4 T cells stained with mitochondrial dyes were adhered to slides by cytospin and fixed in 4% paraformaldehyde for 15 minutes at room temperature. For ubiquitin stain, cells were permeabilized in 0.1% Triton X-100 for 5 minutes and blocked in 5% casein in PBS for 1 hour at room temperature, followed by antibody staining in 0.1% Triton X-100 with 2% BSA. Nuclei were labeled with DAPI (2 μg/ml). Cells were imaged in mounting media (Life Technologies). All images were acquired using a confocal microscope (LSM710; Carl Zeiss) with a 25X or 63X oil immersion objective. Images were processed and analyzed using ImageJ software (version 1.41; National Institutes of Health).
Colocalization analysis and code availability
To calculate ubiquitin co-localization with mitochondria, pixels positive for the MitoTracker stain were identified, and for each MitoTracker + pixel the ratio of ubiquitin intensity to MitoTracker intensity was calculated. This ratio was averaged over 3 z-slices per cell. Each point on the graph represents 1 cell. The colocalization program (ImageJ software, version 1.41, National Institutes of Health) used to analyze ubiquitin deposition on mitochondria is provided as Supplementary Text.
In vitro survival assay
Sorted naïve T cells were plated at a density of 10 6 cells per well in 24-well plates and were cultured at 37 °C in RPMI 1640 medium containing HEPES (10 mM) pH 7.2, penicillin (50 IU/ml), streptomycin (50 μg/ml), β-mercaptoethanol (50 μM), 10% FBS, and IL7 (0.01-10 ng/ml) (Peprotech). After 5 days, cells were collected, stained with propidium iodide (Biolegend), and analyzed by flow cytometry.
T cell activation
Freshly isolated LN T cells were stained for 20 min at 37°C with 5 μM CellTrace Violet (Molecular Probes/ThermoFisher) in PBS with 0.1% BSA. 4 × 10 5 T cells were plated in each well of a 48-well plate, pre-coated with 4 μg/ml anti-CD3 (clone 145-2C11), in activation medium containing 2 μg/mL anti-CD28 (clone 37.51). Activation medium contained glucose-free RPMI 1640 (Gibco) with 10% dialyzed fetal bovine serum (Gibco), 2 mM glutamine (Mediatech), non-essential amino acids (Hyclone), 1 mM sodium pyruvate (Hyclone), and 55 mM 2-mercaptoethanol (Invitrogen), supplemented with either glucose (2 g/L) or galactose (2 g/L). After 72 hours, cells were counted and CellTrace Violet dilution was assayed by flow cytometry.
Western blot
Cells were lysed in RIPA buffer containing phosphatase and protease inhibitor cocktails (Roche). Lysates were resolved by SDS-PAGE followed by Western blot using HRPconjugated secondary antibodies (Jackson ImmunoResearch Laboratories) and SuperSignal West Pico Chemiluminescent Substrate or SuperSignal West Femto Maximum Sensitivity Chemiluminescent Substrate (Thermo Scientific). Signal was detected using a Chemidoc MP System and quantified using Image Lab software (Bio-Rad Laboratories); there were no saturated pixels in any quantified images. For IL7 stimulation, CD4 + T cells were isolated from LN and stimulated ex vivo with IL7 (Peprotech) for 5 minutes at 37°C. For S1P stimulation, CD4 T cells were isolated from LN and incubated ex vivo with 1 μM S1P (Sigma) for 3 hours at 37°C. The cytoplasmic fraction was isolated using NE-PER nuclear and cytoplasmic extraction reagents (Thermo Scientific), according to the manufacturer's instructions.
RNA-Seq
Total RNA was extracted from samples using the RNeasy Plus Mini kit (Life Technologies). Samples were then subject to poly(A) selection using oligo-dT beads (Life Technologies) according to the manufacturer's instructions. RNA samples were used as input for library construction using TotalScript RNA-Seq Kit (Epicentre) according to the manufacturer's instructions. RNA libraries were sequenced on an Illumina HiSeq 2500 (HiSeq Single Read 50 Cycle Lane). Raw sequencing data passed quality control checks performed using FastQC (version 0.11.3). Sequenced reads were aligned to the mouse genome (version mm10 from UCSC) using STAR (version 2.4). Aligned reads were then quantified using HTSeq (version 0.6.0) for raw counts and CuffLinks (version 2.2.1) for FPKM against the UCSC mm10 reference annotation. Initial expression data clustering revealed a batch effect due to variation between experimental days. The expression was corrected for batch effects using R package ComBat (Bioconductor Release 3.3) and a two-factor analysis for genotype and experimental day. R package Limma (Bioconductor Release 3.3) was used to identify differentially expressed genes. Genes significantly differentially expressed with a Benjamini-Hochberg adjusted p-value <0.05 (FDR=0.05) were selected. Pathway analysis on these genes was performed using Ingenuity Pathway Analysis (Qiagen, version 1.0). We show genes that fall into Ingenuity Pathway Analysis' "Molecular and Cellular Functions" category, with the annotation "Cell death and survival." Heat maps were created using batchcorrected expression values that were log-normalized (log2[Expression +1]) using ggplot2 library in R (Bioconductor Release 3.3).
Mitochondrial function
Mitochondrial function of sorted naïve T cells was assessed using Seahorse XF Cell Mito Stress Test Kit (Agilent Technologies) according to the manufacturer's instructions. In brief, sorted naïve T cells were plated in Seahorse XF Base Medium supplemented with 1 mM pyruvate, 2 mM glutamine, and 10 mM glucose (pH 7.4) in Seahorse XF96 Cell Culture microwell plates coated with CellTak (Corning). Cells were incubated for 45 minutes at 37°C without CO 2 before running the assay. Samples were then run on a Seahorse XF e 96 Extracellular Flux Analyzer (Agilent Technologies) using the Seahorse XF Cell Mito Stress Test kit with 1 μM Oligomycin, 1 μM FCCP, and 0.5 μM Rotenone/Antimycin A. All samples were run in duplicate or triplicate. Equivalent cell numbers per sample were confirmed post-run by analyzing DNA content.
RT-qPCR
Total RNA was extracted from sorted cell populations using TRIzol (Invitrogen) according to the manufacturer's instructions. Before reverse transcription, RNA was treated with DNase I (Invitrogen). The RNA was converted to cDNA with Invitrogen's Superscript III First Strand Synthesis System according to the manufacturer's instructions, using a mix of oligo dT and random hexamers as primers. Real-time quantitative PCR (qPCR) was To control for DNA contamination, a reaction without reverse transcriptase was performed in parallel for each sample/primer pair. To control for nonspecific amplification, the size of the reaction products was analyzed by agarose gel electrophoresis. Primer pairs were tested for linear amplification over two orders of magnitude.
Statistics
All comparisons are by Student's 2-tailed unpaired t-test, except comparisons of protein abundance by Western blot, which are by Student's 2-tailed paired t-test. When data are plotted on a log-scale, log-transformed data are compared. For all graphs, bars or lines indicate mean and error bars indicate SEM. Sample sizes were chosen based on our experience with mouse models. In the case of negative results, we do not exclude the possibility that a difference would have been revealed with a larger sample size.
Data Availability
RNA-Seq data has been deposited with NIH/NCBI as GEO dataset GSE97249. Spns2Δ mice have normal plasma S1P and egress from the spleen into blood proceeds as usual, but in Spns2Δ mice lymph S1P is lost and egress from lymph nodes is blocked. Over time, this leads to a redistribution of T cells from spleen to lymph nodes and a loss of circulating cells, because any cell that leaves the spleen and enters a lymph node is trapped.
(b) Representative surface S1PR1 on naïve CD4 + T cells in the blood and spleen (top panels) and in the lymph and LN (bottom panels) of a Spns2Δ mouse and its littermate control (Ctrl). Surface S1PR1 on T cells is internalized upon binding S1P. Hence the lower S1PR1 on the surface of T cells in blood than spleen, in both Spns2Δ and control animals, indicates that T cells sense more S1P in blood than spleen. S1PR1 is also lower on the surface of T cells in lymph than LN of control mice. But in Spns2Δ mice S1PR1 is equally high on T cells in lymph and LN, suggesting that the gradient that directs T cell exit from LN has been ablated. pairs of mice analyzed in 5 experiments. There is no statistically significant difference in death of naïve CD4 or CD8 T cells in the spleen of Spns2Δ mice compared to littermate controls, although there seems to be a trend towards increased death in Spns2Δ mice. Normal T cell survival in the spleen of Spns2Δ mice is consistent with normal blood S1P and normal S1P production by blood vessel endothelial cells lining the marginal sinus, which likely maintain normal S1PR1 signaling in T cells in the spleen. We hypothesize that the few T cells able to leave the LN of Spns2Δ mice are relatively healthy, and stabilized while they are in the spleen. However, we hesitate to over-interpret these results because very few T cells remain in the spleen of Spns2Δ animals, and they may be different in a way 
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